Indeed, PDPN may serve as a chemotherapeutic target for primary and metastatic cancer cells, particularly oral squamous cell carcinoma (OSCC) cells that cause most oral cancers. This evidence concerns the gene PDPN and lip and oral cavity carcinoma.